$BBNX Q3 '26 Earnings Results & Recap
• Reported GAAP EPS of -$0.52 down -57.58% YoY
• Reported revenue of $35.51M up 30.31% YoY
• Beta Bionics estimates FY2026 total revenue of approximately $124M to $126M, gross margin of 58.5% to 59.5%, and 37% to 39% of new patient starts reimbursed through PBP.